Table 1 of Mookherjee, Mol Vis 2011; 17:2618-2627.

Table 1. Distribution of age and gender in patient and control cohorts.


Study
phase
Patient
subgroup		 Number
of
patients		 Average age
of patients
(±SD)		 Number
of
controls		 Average age
of controls
(±SD)

p- value		 Gender
distribution
in patient		 Gender
distribution
in control

p-value
Phase 1* POAG 323 63.5±10 119 57.3±9.7 <0.0001 M-57%,
F-43% M-50.5%, F-49.5% 0.21
Phase 1* Non-HTG 207 65±10 119 57.3±9.7 <0.0001 M-61%,
F-39% M-50.5%, F-49.5% 0.06
Phase 1* HTG 116 60±10 119 57.3±9.7 0.0506 M-50%,
F-50% M-50.5%, F-49.5% 0.95
Phase 2# HTG 116 60±10 303 50.5±10 <0.0001 M-50%,
F-50% M-55%,
F-45% 0.31

*In phase 1 of the study, a total 10 SNPs (rs1971050, rs1993465, rs13153937, rs10038177, rs11241095, rs10043631, rs10038058, rs10491424, rs17553936, and rs13186912) were genotyped in 323 POAG patients (207 non-HTG, 116HTG) and 119 controls. #In phase 2 of the study only the SNP (rs10038177) found significantly associated in the first phase was genotyped in an additional 184 controls for providing additional power to the study.

Mookherjee, Mol Vis 2011; 17:2618-2627. http://www.molvis.org/molvis/v17/a283

©2011 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535